SCHEMBL6019249

SCHEMBL6019249

CC(C(=O)N1CN(C(=O)C(C)c2cc(C(C)(C)C)c(O)cc2C(C)(C)C)CN(C(=O)C(C)c2cc(C(C)(C)C)c(O)cc2C(C)(C)C)C1)c1cc(C(C)(C)C)c(O)cc1C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
MAPT P10636 1/20 0.46
ATP2A2 P16615 1/20 0.46
ATP2A3 Q93084 1/20 0.46
HSP90AA1 P07900 9/20 0.40
HSP90AB1 P08238 7/20 0.40
GAA P10253 1/20 0.39
TP53 P04637 3/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A4 P08684 2/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692694 0.79 ALOX15 (0.54) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL8466395 0.77 CYP3A4 (0.45) ALDH1A1CYP1A2HSP90AA1HSP90AB1GAA
SCHEMBL11462442 0.77 ALOX15 (0.41) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL78348 0.75 CACNA1A (0.41) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL28163600 0.75 ALDH1A1 (0.48) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL10939458 0.73 ALOX15 (0.65) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL1277895 0.69 ALOX15 (0.48) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
Bicarbonate SCHEMBL11614213 0.68 ALDH1A1 (0.79) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL7185804 0.68 CACNA1A (0.37) ALOX15ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL38604 0.67 ALOX15 (1.00) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060173107-A1 Graftable hindered amine light stabilizers CIBA SPECIALTY CHEMICALS CORP. 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173107-A1 Graftable hindered amine light stabilizers IDO1, MAOA, TPH1 ALOX15 300/4885ALDH1A1 50/4885SMN1; SMN2 1615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.